Zerodha > Trade @ ₹20 (Free Delivery)Know More
Free Account Opening + AMC Free Demat

Ospyn Technologies IPO vs Speciality Medicines IPO

Comparison between Ospyn Technologies IPO and Speciality Medicines IPO.

IPO Details

Ospyn Technologies IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Speciality Medicines IPO is a SME Bookbuilding proposed to list at BSE SME.

 Ospyn Technologies IPOSpeciality Medicines IPO
LogoOspyn Technologies IPO LogoSpeciality Medicines IPO Logo
Issue CategorySMESME
Issue TypeIPOIPO
Process TypeBookbuildingBookbuilding
Listing AtBSE SMEBSE SME
Lead ManagersGYR Capital Advisors Pvt.Ltd.Ekadrisht Capital Pvt.Ltd.
RegistrarKfin Technologies Ltd.Skyline Financial Services Pvt.Ltd.
Market Maker
DRHPDRHP DRHP
RHPRHP RHP
Anchor Investor
IPO Allotment URL

Issue Size and Price

The total issue size of Ospyn Technologies IPO is up to ₹0.00 Cr whereas the issue size of the Speciality Medicines IPO is up to ₹0.00 Cr. The final issue price of Ospyn Technologies IPO is and of Speciality Medicines IPO is .

 Ospyn Technologies IPOSpeciality Medicines IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final)
Discount (Retail)
Discount (Employee)
Market Lot Size
Fresh Issue Size55,00,000 shares23,00,000 shares
Fresh Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total55,00,000 shares23,00,000 shares
Issue Size Total (Amount)up to ₹0.00 Crup to ₹0.00 Cr

IPO Timetable

Ospyn Technologies IPO opens on , while Speciality Medicines IPO opens on . The closing date of Ospyn Technologies IPO and Speciality Medicines IPO is , and , respectively.

 Ospyn Technologies IPOSpeciality Medicines IPO
Anchor Bid Date
Issue Open
Issue Close
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials & KPIs

Ospyn Technologies IPO P/E ratio is , as compared to Speciality Medicines IPO P/E ratio of .

 Ospyn Technologies IPOSpeciality Medicines IPO
Financials

Ospyn Technologies Limited Financial Information (Restated Consolidated)

Period Ended31 Mar 2024
Assets36.01
Total Income33.59
Profit After Tax5.64
Net Worth20.55
Reserves and Surplus6.55
Total Borrowing6.69
Amount in ₹ Crore

Speciality Medicines Limited Financial Information (Restated)

Period Ended31 May 202431 Mar 202431 Mar 202331 Mar 2022
Assets26.4423.4313.265.78
Total Income8.3727.6623.2640.45
Profit After Tax2.34.551.691.48
Net Worth19.2316.615.871.93
Reserves and Surplus14.0811.52.051.72
Total Borrowing2.532.863.641.18
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)94.8062.70
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE40.44%
ROCE34.95%
Debt/Equity0.330.17
EPS₹7.06
RoNW27.42%27.36%

Shares Offered

In the Ospyn Technologies IPO Retail Individual Investors (RII) are offered while in Speciality Medicines IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Ospyn Technologies IPO and in Speciality Medicines IPO.

 Ospyn Technologies IPOSpeciality Medicines IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Ospyn Technologies IPO subscribed in total, whereas Speciality Medicines IPO subscribed .

 Ospyn Technologies IPOSpeciality Medicines IPO
QIB (times)
NII (times)
Big NII (times)
Small NII (times)
RII (times)
Employee (times)
Other (times)
Total (times)